HUM vs MRVI · P/E 39, rev $129.66B vs rev $259.2M
Humana Inc (HUM) versus Maravai Lifesciences Holdings Inc (MRVI) — a side-by-side from cached financials, not a winner call.
Humana Inc (HUM) is a healthcare plans company listed on NYSE.
Maravai Lifesciences Holdings Inc (MRVI) is a biotechnology company listed on NASDAQ.
Latest reported HUM revenue for 2025-12-31 was $129.66B. Net income was $1.19B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. HUM currently screens at market cap $43.46B and trailing P/E 38.6.
Latest reported MRVI revenue for 2024-12-31 was $259.2M. Net income was -$259.6M. MRVI currently screens at market cap $1.93B.
HUM currently screens at market cap $43.46B and trailing P/E 38.6. MRVI currently screens at market cap $1.93B.
Not investment advice. Open the HUM and MRVI stock pages for the full models.
Not investment advice.